has announced it will offer its full portfolio of 500 drugs on a not-for-profit basis to dozens of low-income countries — but critics labeled the move a 'PR spin' from a company 'obsessed with making obscene profits'.The pharma giant today announced it would allow access to 500 patented and generic medicines and vaccines to 45 countries, mostly in the Middle East and Africa.This includes the company's flagship Covid vaccnie, chemotherapies, oral treatments, a range of antibiotics, and any future medicines and shots Pfizer launches.
Load More
Load More